Lyell Immunopharma, Inc. (LYEL)

Lyell Immunopharma Revenue

Lyell Immunopharma had revenue of $2.00K in the quarter ending March 31, 2026, a decrease of -71.43%. This brings the company's revenue in the last twelve months to $31.00K, down -52.31% year-over-year. In the year 2025, Lyell Immunopharma had annual revenue of $36.00K, down -40.98%.

• Revenue (ttm): $31.00K
• Revenue Growth: -52.31%
• P/S Ratio: 9,009.97
• Revenue / Employee: $193
• Employees: 161
• Market Cap: 279.31M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	36.00K	-25.00K	-40.98%
Dec 31, 2024	61.00K	-69.00K	-53.08%
Dec 31, 2023	130.00K	-84.55M	-99.85%
Dec 31, 2022	84.68M	74.03M	695.15%
Dec 31, 2021	10.65M	2.89M	37.31%
Dec 31, 2020	7.76M	7.10M	1,080.52%
Dec 31, 2019	657.00K	-	-

Data Source: Fiscal.ai Last updated: May 6, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 3, 2026

Data Sources Report a data error